Home
Subscription
January 2025 issue
BACK ISSUES
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2018 Issues
December 2018 Issue
• Feature: For Those Without a Voice or Choice – A Gift of Life
• New Drug Review: Fremanezumab-vfrm (Ajovy)
• Appreciation
• Index for Volume 13, 2018
November 2018 Issue
• Feature: Nicotine, Cigarettes, JUUL, Chantix, FDA Talk, Chain Pharmacy Hypocrisy, and Boards of Pharmacy Inertia
• New Drug Review: Baloxavir marboxil (Xofluza)
October 2018 Issue
• Feature: The Drug Pricing Blame Games
• New Drug Review: Erenumab-aooe (Aimovig)
September 2018 Issue
• Feature: Reducing Drug Costs – PBMs are Not Needed and Should Not be Used!
August 2018 Issue
• Feature: THE CORPORATE DESTRUCTION OF HEALTH CARE: Part 2
• New Drug Review: Betrixaban (Bevyxxa)
July 2018 Issue
• Feature: THE CORPORATE DESTRUCTION OF HEALTH CARE: Part 1, And Health Professionals are Letting It Happen!
• Table: New Therapeutic Agents Marketed in the United States in 2017
June 2018 Issue
• Feature: Chain Pharmacists of America (CPOA): Part 2
• Why CVS Loves ObamaCare
• New Drug Review: Delafloxacin meglumine (Baxdela)
May 2018 Issue
• Feature: Chain Pharmacists of America (CPOA)
• New Drug Review: Ertugliflozin L-pyroglutamic acid (Steglatro
April 2018 Issue
• Feature: National Pharmacy Associations Announce Historic Merger!
• New Drug Review: Wonder Drug Inspires Deep, Unwavering Love of Pharmaceutical Companies
March 2018 Issue
• Feature: Merger Mania – Bigger Isn't Better!
• New Drug Review: Semaglutide (Ozempic)
February 2018 Issue
• Feature: Independent Pharmacies and the Fight for Survival
January 2018 Issue
• Feature: The FTC Must Prevent CVS from Acquiring Aetna, and Require CVS to Divest Caremark!
| |
